Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation.

Amy B Cadwallader, Douglas E Rollins, Carol S Lim
Author Information
  1. Amy B Cadwallader: Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, 417 Wakara Way, Suite 2111, Salt Lake City, Utah 84108, USA.

Abstract

Although the qualitative nucleocytoplasmic transport of nuclear hormone receptors (NHRs) has been studied, there is little documentation of the cellular kinetics of this transport. Here, translocation studies using the human androgen receptor (hAR) and the human glucocorticoid receptor (hGR) were performed to aid in identifying the mechanism by which anabolic-androgenic steroids (AAS) were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR. The real-time analysis of EGFP-labeled hAR and hGR ligand-induced cytoplasm-to-nucleus translocation was performed using fluorescence microscopy to better understand the action of these NHRs in a physiologically relevant cell-based model. After transient transfection, the hAR and hGR individually translocate as expected (i.e., transport is ligand-induced and dose-dependent) in this model biological system. Testosterone (TEST) had the fastest translocation rate for the hAR of 0.0525 min(-1). The other endogenous steroids, androstenedione (ANE) and dihydrotestosterone (DHT), had considerably lower hAR transport rates. The rates of hAR transport for the exogenous steroids methyltrienelone (MET), nandrolone (NAN), and oxandrolone (OXA) are lower than that of testosterone and similar to those of the endogenous steroids ANE and DHT. The hGR transport rates for cortisol (COR) and dexamethasone (DEX) are also presented. The synthetic GC, DEX, had a more rapid translocation rate (0.1599 min(-1)) at the highest dose of 100 nM compared to the endogenous GC COR (0.0431 min(-1)). The data obtained agrees with the existing qualitative data and adds an important ligand-dependent kinetic component to hAR and hGR transport. These kinetic data can aid our understanding of NHR action and interaction with other regulatory proteins, and can be useful in the development of new therapies.

References

  1. Mol Biol Cell. 1999 Feb;10(2):471-86 [PMID: 9950689]
  2. Mol Cell Biol. 2001 Feb;21(3):781-93 [PMID: 11154266]
  3. J Biol Chem. 2003 Apr 4;278(14):12425-32 [PMID: 12506123]
  4. J Cell Biochem. 2006 Jul 1;98(4):770-88 [PMID: 16440331]
  5. J Cell Sci. 2008 Apr 1;121(Pt 7):957-68 [PMID: 18319300]
  6. Am J Physiol. 1975 Nov;229(5):1381-6 [PMID: 173192]
  7. J Steroid Biochem. 1986 Feb;24(2):481-7 [PMID: 3486322]
  8. Genes Dev. 1998 Nov 1;12(21):3343-56 [PMID: 9808622]
  9. J Med Chem. 2004 Nov 4;47(23):5690-9 [PMID: 15509168]
  10. J Biol Chem. 2005 Mar 4;280(9):8060-8 [PMID: 15563469]
  11. Endocrinology. 2008 Aug;149(8):3960-9 [PMID: 18420738]
  12. J Steroid Biochem Mol Biol. 2006 Apr;99(1):50-8 [PMID: 16524719]
  13. AAPS PharmSci. 2002;4(3):E18 [PMID: 12423067]
  14. Sports Med. 2004;34(8):513-54 [PMID: 15248788]
  15. Pharm Res. 2003 Oct;20(10):1574-80 [PMID: 14620510]
  16. Mol Endocrinol. 2000 Aug;14(8):1162-74 [PMID: 10935541]
  17. Neuroendocrinology. 2007;85(3):186-92 [PMID: 17446698]
  18. J Neurosci. 2004 May 26;24(21):4918-27 [PMID: 15163683]
  19. Mol Endocrinol. 1999 Mar;13(3):440-54 [PMID: 10077001]
  20. J Histochem Cytochem. 2007 Jun;55(6):535-44 [PMID: 17312014]
  21. Mol Endocrinol. 1999 Nov;13(11):1855-63 [PMID: 10551779]
  22. Mol Cell Endocrinol. 1997 Apr 25;129(1):17-26 [PMID: 9175625]
  23. J Biol Chem. 2003 Oct 24;278(43):41998-2005 [PMID: 12923188]
  24. Mol Endocrinol. 2001 Jul;15(7):1077-92 [PMID: 11435609]
  25. J Steroid Biochem. 1988 Jun;29(6):575-81 [PMID: 3386225]
  26. Mol Biol Cell. 2004 May;15(5):2276-86 [PMID: 15004228]
  27. Mol Endocrinol. 2002 Dec;16(12):2706-19 [PMID: 12456792]
  28. Proc Natl Acad Sci U S A. 1996 May 14;93(10):4845-50 [PMID: 8643491]
  29. Mol Cell Biol. 2003 Mar;23(6):1922-34 [PMID: 12612067]
  30. Annu Rev Cell Dev Biol. 1999;15:607-60 [PMID: 10611974]
  31. Chem Res Toxicol. 2003 Oct;16(10):1338-58 [PMID: 14565775]
  32. Endocrinology. 2002 May;143(5):1889-900 [PMID: 11956172]
  33. J Steroid Biochem Mol Biol. 2005 Mar;94(4):319-26 [PMID: 15857751]
  34. J Biol Chem. 2001 Jul 27;276(30):28395-401 [PMID: 11369770]
  35. J Pharmacol Exp Ther. 2003 Oct;307(1):110-6 [PMID: 12954798]
  36. J Control Release. 2004 Aug 27;98(3):379-93 [PMID: 15312994]
  37. J Steroid Biochem Mol Biol. 2003 Oct;87(1):27-34 [PMID: 14630088]
  38. Mol Endocrinol. 2006 May;20(5):1048-60 [PMID: 16373395]
  39. Mol Endocrinol. 2000 Dec;14(12):2024-39 [PMID: 11117532]
  40. Arch Histol Cytol. 2001 Oct;64(4):353-68 [PMID: 11757905]
  41. Med Sci Sports Exerc. 1990 Jun;22(3):331-40 [PMID: 2199753]
  42. J Biomol Screen. 2007 Dec;12(8):1029-41 [PMID: 17989426]
  43. Mol Endocrinol. 2002 Apr;16(4):694-706 [PMID: 11923466]
  44. J Control Release. 2007 Jul 31;120(3):220-32 [PMID: 17574289]
  45. Recent Prog Horm Res. 2002;57:411-34 [PMID: 12017555]
  46. Mol Endocrinol. 2007 Sep;21(9):2071-84 [PMID: 17579212]
  47. Chem Rev. 2005 Sep;105(9):3352-70 [PMID: 16159155]
  48. Exerc Sport Sci Rev. 1993;21:135-67 [PMID: 8099329]

Grants

  1. F31DA022809/NIDA NIH HHS
  2. R21 DK070060/NIDDK NIH HHS
  3. R01 DA007820/NIDA NIH HHS
  4. DA07820/NIDA NIH HHS
  5. F31 DA022809/NIDA NIH HHS
  6. R01 DA007820-12/NIDA NIH HHS
  7. R21 DK070060-02/NIDDK NIH HHS
  8. F31 DA022809-02/NIDA NIH HHS
  9. DK070060/NIDDK NIH HHS
  10. F31 DA022809-01A1/NIDA NIH HHS

MeSH Term

Anabolic Agents
Androgens
Animals
COS Cells
Chlorocebus aethiops
Green Fluorescent Proteins
Humans
Microscopy, Fluorescence
Protein Transport
Receptors, Androgen
Receptors, Glucocorticoid
Recombinant Proteins

Chemicals

AR protein, human
Anabolic Agents
Androgens
Receptors, Androgen
Receptors, Glucocorticoid
Recombinant Proteins
enhanced green fluorescent protein
Green Fluorescent Proteins

Word Cloud

Created with Highcharts 10.0.0hARhGRtransporttranslocationsteroids0min-1endogenousratesdataqualitativenucleocytoplasmicNHRskineticsusinghumanreceptorglucocorticoidperformedaidanabolic-androgenicinteractingligand-inducedactionmodelrateANEDHTlowerCORDEXGCkineticcanAlthoughnuclearhormonereceptorsstudiedlittledocumentationcellularstudiesandrogenidentifyingmechanismAASactivatingpotentiallyligandsreal-timeanalysisEGFP-labeledcytoplasm-to-nucleusfluorescencemicroscopybetterunderstandphysiologicallyrelevantcell-basedtransienttransfectionindividuallytranslocateexpectediedose-dependentbiologicalsystemTestosteroneTESTfastest0525androstenedionedihydrotestosteroneconsiderablyexogenousmethyltrieneloneMETnandroloneNANoxandroloneOXAtestosteronesimilarcortisoldexamethasonealsopresentedsyntheticrapid1599highestdose100nMcompared0431obtainedagreesexistingaddsimportantligand-dependentcomponentunderstandingNHRinteractionregulatoryproteinsusefuldevelopmentnewtherapiesEffectglucocorticoids

Similar Articles

Cited By